Chronic Diseases
UBC is playing a key role in understanding and preventing chronic diseases like diabetes and arthritis. With a commitment to evidence-based practice, our researchers are generating new knowledge that is reshaping how we treat and manage complex diseases.
Spotlight
The trial provides people in northern communities the opportunity to participate in research on a potential treatment for chronic kidney disease.
UBC researchers have developed a new targeted drug delivery method for conditions like inflammatory bowel disease.
New UBC Medicine research shows how insulin-triggering nutrients vary from person to person.
New UBC study examines the link between hearing loss and activity levels.
New UBC research highlights safety and efficacy of sublingual immunotherapy for older and high-risk children with food allergies.
UBC’s Dr. Paul Yong is helping ignite change for thousands of people faced with the painful disorder.
A clinical trial led by UBC researchers shows that an innovative treatment can help reduce dependence on insulin injections for people with Type 1 diabetes.
Clinical researcher Dr. Eduardo Navajas is part of the first clinical trial for a gene therapy to treat wet age-related macular degeneration.
New UBC research reveals that hospital admissions for COPD have risen, even while smoking rates and admissions for other health issues have declined.
Several common childhood allergies may all stem from the community of bacteria living in our gut, suggesting new ways to predict and prevent them.